The new top 20 phar­ma list: Take­da jumps on, Bio­gen pushed out — and more big changes are on the way

Christophe We­ber Take­da

Take­da CEO Christophe We­ber is get­ting the Big Phar­ma sta­tus he want­ed with his $62 bil­lion Shire buy­out. The phar­ma com­pa­ny, with a big R&D hub in Boston/Cam­bridge, has leapt on to the top 20 list of the world’s largest phar­ma caps, as ranked by Glob­al­Da­ta us­ing end-of-Q1 mar­ket caps.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER